BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)

BACKGROUND: Patients with schizophrenia may benefit from treatment with long-acting injectable (LAI) formulations of antipsychotics. Aripiprazole once-monthly (AOM) is an LAI that was tested in two non-interventional studies in Germany and Canada. METHODS: Here, we report on analyses of pooled data...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöttle, Daniel, Janetzky, Wolfgang, Therrien, Francois, Wiedemann, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015766/
https://www.ncbi.nlm.nih.gov/pubmed/36918846
http://dx.doi.org/10.1186/s12888-023-04651-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015766/
https://www.ncbi.nlm.nih.gov/pubmed/36918846
http://dx.doi.org/10.1186/s12888-023-04651-w

Ejemplares similares